These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11447388)

  • 21. [A study of aggravation of atopic dermatitis during Japanese cedar pollen season--correlation with grades of dermatitis on face and Cry j 1 specific IgE].
    Aihara M; Takahashi S; Oosuna I; Yasueda H; Tsubaki K; Ikezawa Z
    Arerugi; 1999 Oct; 48(10):1172-9. PubMed ID: 10554404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of B- and T-cell responses and HLA-DR4 binding motifs of the latex allergen Hev b 6.01 (prohevein) and its post-transcriptionally formed proteins Hev b 6.02 and Hev b 6.03.
    Raulf-Heimsoth M; Rozynek P; Brüning T; Rihs HP
    Allergy; 2004 Jul; 59(7):724-33. PubMed ID: 15180759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
    Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy.
    Yang L; Suzuki K; Hirose S; Wakasa Y; Takaiwa F
    Plant Biotechnol J; 2007 Nov; 5(6):815-26. PubMed ID: 17714439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis.
    Okano M; Otsuki N; Azuma M; Fujiwara T; Kariya S; Sugata Y; Higaki T; Kino K; Tanimoto Y; Okubo K; Nishizaki K
    Clin Exp Allergy; 2008 Dec; 38(12):1891-900. PubMed ID: 19016801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response.
    Toda M; Kasai M; Hosokawa H; Nakano N; Taniguchi Y; Inouye S; Kaminogawa S; Takemori T; Sakaguchi M
    Eur J Immunol; 2002 Jun; 32(6):1631-9. PubMed ID: 12115646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis.
    Van Hoang V; Ochi T; Kurata K; Arita Y; Ogasahara Y; Enomoto K
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):261-268. PubMed ID: 29094185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.
    Ishii M; Koyama A; Iseki H; Narumi H; Yokoyama N; Kojima N
    Int Immunopharmacol; 2010 Sep; 10(9):1041-6. PubMed ID: 20584630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of nasal blockage in a Japanese cedar pollen-induced allergic rhinitis model mouse.
    Ogita-Nakanishi H; Nabe T; Mizutani N; Fujii M; Kohno S
    Allergol Int; 2009 Jun; 58(2):171-8. PubMed ID: 19240378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of efficacy for Japanese cedar pollen-specific immunotherapy by lymphocyte proliferation test].
    Imai T; Nohara O; Katayama N; Endo T; Inoue S; Sakaguchi M; Taniguchi Y; Nakagawa T; Saito S
    Arerugi; 1996 Nov; 45(11):1172-80. PubMed ID: 8990529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y; Takagi H; Hirose S; Yang L; Saeki M; Nishimura T; Kaminuma O; Hiroi T; Takaiwa F
    Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune regulation by CD4+CD25+ regulatory T cells in patients with Japanese cedar pollinosis.
    Yamanishi T; Chikamatsu K; Takahashi G; Endo S; Masuyama K
    Int Arch Allergy Immunol; 2011; 156(2):187-95. PubMed ID: 21597299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen.
    Miyaji K; Okamoto N; Saito A; Yasueda H; Takase Y; Shimakura H; Saito S; Sakaguchi M
    Allergol Int; 2016 Jul; 65(3):286-92. PubMed ID: 26916996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification, identification, and cDNA cloning of Jun a 2, the second major allergen of mountain cedar pollen.
    Yokoyama M; Miyahara M; Shimizu K; Kino K; Tsunoo H
    Biochem Biophys Res Commun; 2000 Aug; 275(1):195-202. PubMed ID: 10944464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of serum IgE antibodies against Japanese cedar pollen (Cryptomeria japonica) in Japanese monkeys (Macaca fuscata) with pollinosis.
    Sakaguchi M; Inouye S; Imaoka K; Miyazawa H; Hashimoto M; Nigi H; Nakamura S; Gotoh S; Minezawa M; Fujimoto K
    J Med Primatol; 1992 Aug; 21(6):323-7. PubMed ID: 1297854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunodominance in allergic T-cell reactivity to Japanese cedar in different geographic cohorts.
    Oseroff C; Pham J; Frazier A; Hinz D; Sidney J; Paul S; Greenbaum JA; Vita R; Peters B; Schulten V; Sette A
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):680-689.e1. PubMed ID: 27979027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cDNA cloning and expression of Cry j II the second major allergen of Japanese cedar pollen.
    Komiyama N; Sone T; Shimizu K; Morikubo K; Kino K
    Biochem Biophys Res Commun; 1994 Jun; 201(2):1021-8. PubMed ID: 8002972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens.
    Endo T; Asaka D; Nakayama T; Saito S; Kodama H; Mitsuyoshi R; Takaishi S; Sugimoto N; Omae S; Takagi H; Wakasa Y; Ozawa K; Takano M; Takaiwa F; Kojima H; Saito S
    Int Arch Allergy Immunol; 2021; 182(2):109-119. PubMed ID: 32854094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cloning of a class IV chitinase allergen from Japanese cedar (Cryptomeria japonica) pollen and competitive inhibition of its immunoglobulin E-binding capacity by latex C-serum.
    Fujimura T; Shigeta S; Suwa T; Kawamoto S; Aki T; Masubuchi M; Hayashi T; Hide M; Ono K
    Clin Exp Allergy; 2005 Feb; 35(2):234-43. PubMed ID: 15725197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.